Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-02T22:45:08.888Z Has data issue: false hasContentIssue false

Lymphoproliferative response to fusion proteins of human papillomaviruses in patients with cervical intraepithelial neoplasia

Published online by Cambridge University Press:  15 May 2009

H. A. Cubie
Affiliation:
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG
M. Norval*
Affiliation:
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG
L. Crawford
Affiliation:
Laboratory of Molecular Virology, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX
L. Banks
Affiliation:
Laboratory of Molecular Virology, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX
T. Crook
Affiliation:
Laboratory of Molecular Virology, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX
*
*Author for correspondence.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The cell-mediated immune response (CMI) to E6 and E4 fusion proteins of human papillomavirus type 16 (HPV-16), E6 fusion protein of HPV-18, and to control proteins similarly produced, was analysed in 29 patients with cervical intraepithelial neoplasia (CIN) and in 15 age-matched laboratory personnel using a lymphocyte proliferation assay (LPA).

Type
Research Article
Copyright
Copyright © Cambridge University Press 1989

References

REFERENCES

1.zur Hausen, H, Gissman, HL, Stiner, W, Dippold, W, Dreger, I.Human papillomavirus and cancer. Bibl Haemat 1975; 43: 569–71.Google Scholar
2.Pfister, H.Human papillomavirus and genital cancer. Adv Cancer Res 1987; 48: 113–47.CrossRefGoogle Scholar
3.Campo, MS, Jarrett, WFH. Papillomavirus and disease. In: Russell, WC, Almond, JW, eds. Molecular basis of virus disease. Cambridge University Press: Symposium of the Society for General Microbiology 1987; 40: 215–43.Google Scholar
4.zur Hausen, H.Human genital cancer: synergism between two virus infections or synergism between a virus and initiating events? Lancet 1982; 2: 1370–2.Google Scholar
5.Jablonska, s, Orth, G, Lutzner, MA.Immunopathology of papillomavirus-induced tumours in different tissues. Springer Semin Immunopathol 1982; 5: 3352.CrossRefGoogle ScholarPubMed
6.Lutzner, MA.Immunopathology of papillomavirus-induced warts and skin cancers in immunodepressed and immunosuppressed patients. Springer Semin Immunopathol 1982; 5: 5362.CrossRefGoogle ScholarPubMed
7.Rudlinger, R, Smith, IW, Bunney, MH, Hunter, JAA.Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681–92.CrossRefGoogle Scholar
8.Barr, BBB, Benton, EC, McLaren, K, Bunney, MH, Smith, IW, Blessing, K, Hunter, JAA.Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; i: 124–8.CrossRefGoogle Scholar
9.Kinlen, LJ, Sheil, AGR, Peto, J, Doll, R.Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; ii: 1461–6.Google Scholar
10.Sillman, F, Stanek, A, Sedlis, A et al. , The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 1984; 150: 300–8.CrossRefGoogle ScholarPubMed
11.Shokri-Tabibzadeh, S, Koss, LG, Molnar, J, Romney, S.Association of human papillomavirus with neoplastic processes in the genital tract of four women with impaired immunity. Gynecol Oncol 1981; 12: 5129–40.CrossRefGoogle ScholarPubMed
12.Morison, WL.Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasms. Br J Dermatol 1975; 92: 625–30.Google Scholar
13.Ivanyi, L, Morison, WL.In vitro lymphocyte stimulation by wart antigens in man. Br J Dermatol 1976; 94: 523–7.Google Scholar
14.Lee, AKY, Eisinger, M.Cell mediated immunity (CMI) to human wart virus and wart-associated tissue antigens. Clin Exp Immunol 1976; 26: 419–24.Google Scholar
15.Cubie, HA, Norval, M.Humoral and cellular immunity to papillomaviruses in patients with cervical dysplasia. J Med Virol 1988; 24: 8595.CrossRefGoogle Scholar
16.Smotkin, D, Wettstein, FO.Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986; 83: 4680–4.Google Scholar
17.Androphy, EJ, Hubbert, N, Schiller, J, Lowy, D.Identification of an HPV-16 E6 protein in mammalian cells carrying HPV-16 DNA. EMBO J 1987; 6: 987–92.Google Scholar
18.Seedorf, K, Oltersdorf, T, Krammer, G, Rowekamp, W.Identification of early proteins of the human papillomaviruses type 16 (HPV-16) and type 18 (HPV-18) in cervical carcinoma cells. EMBO J 1987; 6: 139–44.Google Scholar
19.Banks, L, Spence, P, Androphy, E et al. , Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol 1987; 68: 1351–9.Google Scholar
20.Matlashewski, G, Banks, L, Wu-Liao, J, Spence, P, Pim, D, Crawford, L.The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies. J Gen Virol 1986; 67: 1909–16.Google Scholar
21.Ruther, V, Muller-Hill, B.Easy identification of cDNA clones. EMBO J 1983; 2: 1791–4.Google Scholar
22.Norval, M, Howie, SE, Ross, J, Maingay, J.A murine model of herpes simplex virus infection. J Gen Virol 1987; 68: 2693–8.CrossRefGoogle Scholar
23.Vestey, JP, Norval, M, Howie, SEM, Maingay, J, Neill, WA. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections. Clin Exp Immunol. In press.Google Scholar
24.Schiller, JT, Vass, WC, Lowy, DR.Identification of a second transforming region in bovine papillomavirus DNA. Proc Natl Acad Sci USA 1984; 81: 7880–4.Google Scholar
25.Yang, Y-C, Okayamah, H, Howley, PM.Bovine papillomavirus contains multiple transforming genes. Proc Natl Acad Sci USA 1985; 82: 1030–4.Google Scholar
26.Shirasawa, H, Tomita, Y, Sekiya, S, Takamizawa, H, Simizu, B.Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987; 68: 583–91.CrossRefGoogle ScholarPubMed
27.Smotkin, D, Wettstein, FO.The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 1987; 61: 1686–9.Google Scholar
28.Lehn, H, Krieg, P, Sauer, G.Papillomavirus genomes in human cervical tumours: analysis of their transcriptiona activity. Proc Natl Acad Sci USA 1985; 82: 5540–4.Google Scholar
29.Pater, MM, Pater, A.Expression of human papillomavirus types 16 and 18 DNA sequences in cervical carcinoma cell lines. J Med Virol 1988; 26: 185–95.CrossRefGoogle ScholarPubMed
30.Croissant, O, Breitburd, F, Orth, G.Specificity of cytopathic effects of cutaneous human papillomavirus. Clin Dermatol 1985; 3: 4355.CrossRefGoogle Scholar
31.Doorbar, J, Campbell, D, Grand, RJA, Gallimore, PH.Identification of the human papillomavirus-1a E4 gene products. EMBO J 1986; 5: 355–62.CrossRefGoogle Scholar
32.Breitburd, F, Croissant, O, Orth, G.Expression of human papillomavirus type-1 E4 gene product in warts. Cancer Cells 1987; 5: 115–22.Google Scholar
33.Doorbar, J, Evans, SS, Coneron, I, Crawford, LV, Gallimore, P.Analysis of HPV-1 E4 gene expression using epitope defined antibodies. EMBO J 1988; 7: 825–33.Google Scholar
34.Tay, SK, Jenkins, D, Maddox, P, Campion, M, Singer, A.Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol 1987; 94: 10–5.Google Scholar
35.Hughes, RG, Norval, M, Howie, SEM.The expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J Clin Pathol 1988; 41: 253–9.CrossRefGoogle ScholarPubMed
36.Young, LS, Bevan, IS, Johnson, MA, Blomfield, PI, Bromidge, T, Maitland, NJ, Woodman, CBJ.The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Br Med J 1989; 298: 14–8.Google Scholar
37.Tidy, JA, Parry, GCN, Ward, P, Coleman, DV, Peto, J, Malcolm, ADB, Farrell, PJ.High rate of human papillomavirus type 16 infection in cytologically normal cervices. Lancet 1989: 1: 434.CrossRefGoogle ScholarPubMed